Lundbeck
HLUN-B.CO
#2558
Rank
โ‚น467.39 B
Marketcap
โ‚น490.98
Share price
0.05%
Change (1 day)
23.47%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2023 (TTM): โ‚น29.01

According to Lundbeck 's latest financial reports the company's current EPS (TTM) is โ‚น30.88. In 2022 the company made an earnings per share (EPS) of โ‚น23.49 a decrease over its 2021 EPS that were of โ‚น52.75.

EPS history for Lundbeck from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น29.0123.52%
2022โ‚น23.49-55.47%
2021โ‚น52.75-51.83%
2020โ‚น109.50-28.01%
2019โ‚น152.10-44.08%
2018โ‚น271.9951.94%
2017โ‚น179.01126.64%
2016โ‚น78.98-120.84%
2015-โ‚น379.025622.18%
2014-โ‚น6.62-110.03%
2013โ‚น66.02-28.08%
2012โ‚น91.79-52.1%
2011โ‚น191.62-1.31%
2010โ‚น194.1715.61%
2009โ‚น167.95